Vyloo
Active Composition•Lung Cancer
Prescription (Rx)

Osimertinib

3rd-Generation EGFR Tyrosine Kinase Inhibitor (TKI)

Reviewed By Nitin Kumar (D.Pharm, UPPC Reg: 63405)Updated 2026-10-08T21:32:18.963Z

Medicine brands for Osimertinib

Verified branded and generic formulations containing Osimertinib:

Strengths:8040

Osimertinib Uses

This medication is prescribed for the treatment of non-small cell lung cancer (NSCLC) in patients whose tumors have specific EGFR gene mutations. It serves as both an adjuvant therapy following tumor resection surgery to prevent recurrence, and as a primary, first-line treatment for advanced or metastatic NSCLC.

How Osimertinib works

Osimertinib is a targeted cancer therapy that acts as an irreversible inhibitor of the epidermal growth factor receptor (EGFR). It binds directly to the mutant forms of EGFR (such as T790M, L858R, and exon 19 deletions) that signal cancer cells to multiply, effectively blocking their growth pathways while largely sparing healthy, wild-type tissues.

Common side effects of Osimertinib

Most side effects do not require stopping therapy and improve as your body adjusts to the medicine. Consult your oncologist if any symptom worsens or persists.

DiarrheaRashDry skinNail toxicity (paronychia)StomatitisFatigueDecreased appetite

Expert advice for Osimertinib

  • •Take your dose at the same time every day, either with or without food.
  • •Swallow the tablet whole with a glass of water; do not crush, split, or chew it.
  • •Use highly effective, non-hormonal contraception during your treatment and for at least 6 weeks (for females) or 4 months (for males) after the final dose.
  • •Report any sudden worsening of shortness of breath or a persistent cough to your doctor immediately, as this can indicate a rare but serious lung inflammation.
  • •Avoid consuming grapefruit, grapefruit juice, or St. John's Wort, as these can interfere with how your body metabolizes the medicine.

Safety advice for Osimertinib

Pregnancy

Unsafe

Unsafe. Based on its mechanism of action and animal studies, it can cause severe fetal harm.

Breastfeeding

Unsafe

Unsafe. Do not breastfeed during treatment and for at least 2 weeks after the final dose.

Alcohol

Caution

Caution advised. While no direct chemical interaction exists, alcohol can worsen side effects like fatigue, diarrhea, or liver enzyme elevations.

Driving

Safe

Generally safe. However, avoid operating heavy machinery if you experience severe fatigue or vision changes.

Authoritative References & Citations

Clinical pharmacology and monographs verified against official drug regulatory authorities:

1. US FDA Prescribing Information & Package Insert
Source: US FDA•Accessed: 2026-10-08
View Source
2. Central Drugs Standard Control Organization (CDSCO) Approved Oncology List
Source: CDSCO India•Accessed: 2026-10-08
View Source
3. NCCN Clinical Practice Guidelines in Oncology
Source: NCCN Guidelines•Accessed: 2026-10-08
View Source

Editorial & Review Standards: Clinical information is verified by Nitin Kumar, D.Pharm (Diploma in Pharmacy) (UPPC Reg: 63405) in accordance with our Medical Review Policy. Educational only; not a substitute for professional oncological consultation.

Frequently Asked Questions about Osimertinib

Composition Summary

Salt Name
Osimertinib
Drug Class
3rd-Generation EGFR Tyrosine Kinase Inhibitor (TKI)
Storage
Below 30°C
Prescription
Required (Rx)
Indication
Lung Cancer

Oncology Pharmacy Support

Need help checking brand availability, batch certificates, or uploading a doctor prescription?

100% Genuine Pharmacy Guarantee

Sourced directly from licensed oncology pharmaceutical manufacturers with strict temperature controls and verifiable batch authenticity.